Outcome Evaluation of Minority AIDS Initiative Programs in the New York EMA

The recruitment status of this study is unknown because the information has not been verified recently.
Verified September 2006 by The New York Academy of Medicine.
Recruitment status was  Recruiting
Public Health Solutions
Information provided by:
The New York Academy of Medicine
ClinicalTrials.gov Identifier:
First received: January 4, 2006
Last updated: September 21, 2006
Last verified: September 2006

January 4, 2006
September 21, 2006
November 1999
Not Provided
Functional Health Status (ACTG SF-21): at 3, 6, and 12 mos.
Same as current
Complete list of historical versions of study NCT00273403 on ClinicalTrials.gov Archive Site
  • Housing stability: at 3, 6, and 12 months
  • Substance use: at 3, 6, and 12 months
  • Whether receiving HIV primary care: at 3, 6, and 12 months
  • Whether on HIV meds: at 3, 6, and 12 months
Same as current
Not Provided
Not Provided
Outcome Evaluation of Minority AIDS Initiative Programs in the New York EMA
Outcome Evaluation of Minority AIDS Initiative Programs in the New York EMA
This outcome evaluation effort provides the opportunity to learn what programmatic approaches effectively address two of the most difficult hurdles in HIV health services delivery: (1) getting people who would benefit from health care to use it and (2) getting people who do use health care to do so more consistently and effectively. The New York HIV Planning Council (through MHRA) has funded 23 agencies to achieve these objectives for people of color with HIV disease.

All clients are assessed upon entry into the program, have their service utilization tracked, and then are reassessed at three, six, and twelve months following program entry.

The main client-level data elements collected during baseline and follow-up interviews are the following:

  • Biological markers (including HIV status, viral load, t-cell count)
  • Demographic characteristics
  • Adherence to treatment
  • Barriers to care
  • Social support
  • Substance use and treatment
  • Functional health status

Functional Health Status is used in this evaluation as the primary measure of final client “outcomes.” The Functional Health Status items we use are from the ACTG SF-21 (a modified version of the Medical Outcomes Study instrument).

The overall evaluation objectives are to:

  • Describe the change in functional health status for different populations and groups of clients.
  • Identify services or constellations of services and intensity of services associated with change in functional health status.
  • Assess whether programs meet intermediate objectives (decreased drug use, increased service use, improved housing stability).
  • Identify barriers to access to and maintenance in care.
Not Provided
Allocation: Non-Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Treatment
HIV Infections
  • Behavioral: Maintenance in Care Services
  • Behavioral: Access to Care Services
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
November 2006
Not Provided

Inclusion Criteria:

  • HIV-positive
  • Not in HIV care, or difficulty being maintained in HIV care
  • HIV-negative but at high risk of HIV infection

Exclusion Criteria:

  • HIV-negative and not at high risk of HIV infection
Not Provided
Contact: Elana Behar, MA 212-822-7374 ebehar@nyam.org
Contact: John Chin, PhD 212-419-3537 jchin@nyam.org
United States
Not Provided
Not Provided
The New York Academy of Medicine
Public Health Solutions
Principal Investigator: John Chin, PhD New York Academy of Medicine
The New York Academy of Medicine
September 2006

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP